VV vs XBI

Vanguard Large-Cap ETF vs SPDR S&P Biotech ETF

Quick take
  • • VV has the lower expense ratio at 0.03% vs 0.35% for XBI.
  • • VV pays a higher dividend yield (1.03%).

Side-by-side metrics

MetricVVXBI
Expense ratio
Annual fee. Lower is better.
0.03%0.35%
Dividend yield
Trailing 12-month yield.
1.03%0.35%
AUM
Assets under management — bigger funds are typically more liquid.
$74.94B$10.92B
YTD return
11.08%28.80%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.981.01
P/E ratio
24.29—
Last price
$350.87$156.41
Inception
——
Issuer
VanguardState Street

VV top holdings

Top holdings · VV
NVDANVIDIA Corp8.11%
AAPLApple Inc7.54%
MSFTMicrosoft Corp5.91%
AMZNAmazon.com Inc3.75%
GOOGLAlphabet Inc Class A3.13%
AVGOBroadcom Inc2.59%
GOOGAlphabet Inc Class C2.48%
METAMeta Platforms Inc Class A2.48%
MUMicron Technology Inc1.87%
TSLATesla Inc1.55%
Sector breakdown · VV
Real Estate1.5%
Consumer Cyclical8.4%
Basic Materials1.5%
Consumer Defensive4.3%
Technology40.8%
Communication Services10.1%
Financial Services11.3%
Utilities1.7%
Industrials7.7%
Energy3.5%
Healthcare9.2%

XBI top holdings

Top holdings · XBI
MRNAModerna Inc2.37%
NTRANatera Inc1.82%
HALOHalozyme Therapeutics Inc1.77%
TWSTTwist Bioscience Corp1.77%
BIIBBiogen Inc1.75%
AMGNAmgen Inc1.73%
EXELExelixis Inc1.73%
UTHRUnited Therapeutics Corp1.72%
ABBVAbbVie Inc1.71%
GILDGilead Sciences Inc1.70%
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%

About VV

VV (Vanguard Large-Cap ETF) is Tracks the CRSP US Large Cap Index. Managed by Vanguard, the fund carries $74.9B in assets under management, an expense ratio of 0.03%, a dividend yield of 1.03%. Its largest holding is NVIDIA Corp (NVDA), which represents 8.1% of the portfolio. Real Estate is the fund's largest sector exposure at 1.5%.

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.